Initiation of maintenance treatment with salmeterol/fluticasone propionate 50/100 g bd versus fluticasone propionate 100 g bd alone in patients with persistent asthma: Integrated analysis of four randomised trials

Respiratory Medicine

Volumn 101, Issue 11, 2007, Pages 2358-2365

  Barnes, N C ^a   Jacques, L ^b   Goldfrad, C ^b   Bateman, E D ^c  

^a LONDON CHEST HOSPITAL   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Adolescents; Adults; Asthma; Initial maintenance therapy; Salmeterol fluticasone

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; FLUTICASONE PROPIONATE; FLUTICASONE PROPIONATE PLUS SALMETEROL; PLACEBO; SALMETEROL;

ADOLESCENT; ADULT; AGED; AIRWAY OBSTRUCTION; ARTICLE; ASTHMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DISEASE CONTROL; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; DYSPHONIA; FEMALE; FORCED EXPIRATORY VOLUME; HOARSENESS; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; METERED DOSE INHALER; MULTICENTER STUDY; OROPHARYNX CANDIDIASIS; PREDICTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; THROAT IRRITATION; THRUSH;

EID: 34748903470     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2007.06.013     Document Type: Article

References (18)

1. Beasley R., Crane J., Lai C.K., and Pearce N. Prevalence and etiology of asthma. J Allergy Clin Immunol 105 2 (2000) S466-S472
2. Braman S.S. The global burden of asthma. Chest 130 Suppl. (2006) 4-12
3. Masoli M, Fabian D, Holt S, Beasley R for the Global Initiative for Asthma (GINA) Program. The global burden of asthma: executive summary of the GINA Dissemination Committee Report. Allergy 2004; 59(5): 469-478.
4. Global initiative for asthma (GINA). Global strategy for asthma management and prevention. National Institutes of Health publication No. 02-3659; 2006 [revised].
5. Rabe K.F., Adachi M., Lai C., et al. Worldwide severity and control of asthma in children and adults: the global asthma and insights reality surveys. J Allergy Clin Immunol 114 (2004) 40-47
6. Rabe K., Vermeire P., Soriano J., and Maier W. Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study. Eur Respir J 16 (2000) 1-6
7. Lai C., de Guia T., Kim Y.-Y., et al. Asthma control in the Asia-Pacific region: the Asthma Insights and reality in Asia-Pacific Study. J Allergy Clin Immunol 111 (2003) 263-268
8. Neffen H., Fritscher C., Schacht F.C., Levy G., Chiarella P., Soriano J.B., et al., on behalf of the AIRLA survey group. Asthma control in Latin America: the Asthma Insights and Reality in Latin America (AIRLA) survey. Rev Panam Salud Publica 17 (2005) 191-197
9. Greening A.P., Ind P.W., Northfield M., and Shaw G. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Lancet 344 (1994) 219-224
10. Woolcock A., Lundback B., Ringdal N., and Jacques L.A. Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids. Am J Respir Crit Care Med 153 (1996) 1481-1488
11. Ringdal N., Eliraz A., Pruzinec P., et al. The salmeterol/fluticasone combination is more effective than fluticasone plus oral montelukast in asthma. Respir. Med. 97 3 (2003) 234-241
12. 2-agonists. Ann Allergy Asthma Immunol 93 (2004) 351-359
13. Nelson H., Wolfe J., Gross G., et al. Efficacy and safety of FP 44 μg/salmeterol 21 μg administered in a hydrofluoroalkan metered-dose inhaler as an initial asthma maintenance treatment. Ann Allergy Asthma Immunol 91 (2003) 263-269
14. Pearlman D., Peden D., Condemi, et al. Efficacy and safety of fluticasone propionate/salmeterol HFA 134A MDI in patients with mild-to-moderate persistent asthma. J Asthma 41 (2004) 1-10
15. Bateman E., Boushey H., Bousquet J., et al., for the GOAL investigators group. Can guideline-asthma control be achieved? The Gaining Optimal Asthma ControL Study. Am J Respir Crit Care Med 170 (2004) 836-844
16. Clarke T.J.H., Bateman E.D., James M.H., and on behalf of the GOAL Steering Committee. Assessing asthma control using a composite measure based on GINA/NIH guidelines: an analysis of GOAL baseline data. Eur Respir J 20 Suppl. 38 (2002) 47
17. Stoloff S.W., Stempel D.A., Meyer J., Stanford R.H., and Carranza Rosenzweig J.R. Improved refill persistence with FP and salmeterol in a single inhaler compared with other controller therapies. J. Allergy Clin Immunol 113 2 (2004) 245-251
18. Stempel D.A., Stoloff S.W., Carranza Rosenzweig J.R., Stanford R.H., Ryskina K.L., and Legorreta A.P. Adherence to asthma controller medication regimens. Respir Med 99 (2005) 1263-1267